Do you want to read an article? Please log in or register.
COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
COPD
RECOMMENDED
Related content
COPD
Feasibility of deriving a novel imaging biomarker based on patient-specific lung elasticity for characterizing the degree of COPD in lung SBRT patients
Br J Radiol. 2
Hasse K, Neylon J, Min Y, O'Connell D, Lee P, Low DA, Santhanam AP
doi: 10.1259/bjr.20180296.
RECOMMENDED
COPD
Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
Respir Res.
Haghighi B, Choi S, Choi J, Hoffman EA, Comellas AP, Newell JD Jr, Lee CH, Barr RG, Bleecker E, Cooper CB, Couper D, Han ML, Hansel NN, Kanner RE, Kazerooni EA, Kleerup EAC, Martinez FJ, O'Neal W, Paine R 3rd, Rennard SI, Smith BM, Woodruff PG, Lin CL
doi: 10.1186/s12931-
RECOMMENDED
COPD
COPD Biomarkers and their Interpretation
Am J Respir Crit Care Med.
Stockley RA, Halpin DMG, Celli BR, Singh D
doi: 10.1164/rccm.201810-1860SO.
RECOMMENDED
Further Publications
"Protein biomarkers for COPD outcomes"
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Serban KA, Pratte KA, Bowler RP
doi: 10.1016/j.chest.2021.01.004
RECOMMENDED
COPD
Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Nuñez A, Marras V, Harlander M, Mekov E, Turel M, Petkov R, Lestan D, Yanev N, Negri S, Barrecheguren M, Pirina P, Miravitlles M, Esquinas C
doi: 10.1016/j.rmed.2020.106091.
COPD
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Int J Chron Obstruct Pulmon Dis.
Beeh KM, Beier J, Candler H, Wittig T
doi: 10.2147/COPD.S11765
COPD
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort
Ann Am Thorac Soc.
Martinez CH, Murray S, Barr RG, Bleecker E, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper D, Criner GJ, Curtis JL, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Krishnan JA, Lazarus SC, Leidy NK, O'Neal W, Martinez FJ, Paine R 3rd, Rennard SI, Tashkin DP, Woodruff PG, Han MK; Subpopulations and Intermediate Outcome Measures in COPD Study Investigators
doi: 10.1513/
COPD exacerbator phenotype: time for reassessment?
Lancet Respir Med.
Nachef Z, Mador MJ
doi: 10.1016/
IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes
BMC Pulm Med.
Egli A, Mandal J, Schumann DM, Roth M, Thomas B, Lorne Tyrrell D, Blasi F, Kostikas K, Boersma W, Milenkovic B, Lacoma A, Rentsch K, Rohde GGU, Louis R, Aerts JG, Welte T, Torres A, Tamm M, Stolz D
doi: 10.1186/s12890-018-0616-6.